Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 989-1001
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.989
Table 1 Baseline characteristics of patients (n = 551)
CharacteristicsValue
Male sex (%)318/551 (55.7)
Age at diagnosis, yr40.56 ± 16.11
BMI at diagnosis, kg/m222.28 ± 3.19
Family history of IBD (%)51/369 (13.8)
History of smoking (%)77/443 (17.4)
First symptom
Hematochezia388/548 (70.8)
Diarrhea164/548 (29.9)
Abdominal pain39/548 (7.1)
Diagnostic interval, d (median)223.28 ± 483.15 (69)
Time from first symptom to hospital visit, d (median)154.22 ± 379.140 (40)
Time from first hospital visit to diagnosis, d (median)69.06 ± 295.04 (9)
Mayo score at diagnosis (%)
Mild179/399 (44.9)
Moderate204/399 (51.1)
Severe220/399 (4.0)
Disease extent at diagnosis (%)
Proctitis253/547 (46.3)
Left side160/547 (29.3)
Extensive134/547 (24.5)
Steroid (oral or intravenous) use (%)250/551 (45.4)
AZA/6MP use (%)163/551 (29.6)
Anti-TNFα use (%)50/551 (9.1)
Admission due to flare-up (%)121/430 (22.0)
Frequent admission due to flare-up (%)50/551 (9.1)
UC-related surgery (%)7/551 (1.3)
Clinical remission at the latest follow-up (%)333/467 (71.3)